JPRN-UMIN000010991已完成未知
Japanese Alzheimer's Disease Neuroimaging Initiative, Second Stage - J-ADNI2
J-ADNI2 study group0 个研究点目标入组 500 人开始时间: 2013年6月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 60years-old 至 84years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Parkinson' disease, Lewy body dementia, frontotemporal dementia, Huntington's disease, progressive supranuclear palsy or other neurodegenerative diseases other than AD. Multiple cerebral infarction, normal pressure hydrocephalus, brain tumor, epilepsy, subdural hematoma, multiple sclerosis, head trauma with sequelae will also be excluded. 2. Signs of brain infection, focal brain lesions (eg infarction) that may affect cognitive function. Individuals with subcortical small infarction or diffuse white matter lesions can be included except for those in specific lesions affecting cognition. Cortical infarcts are normally excluded. 3. Presence of pacemaker, arterial clip, artificial valves, artificial cochlea, and other magnetic/electroconductive metals in the body that may affect MRI scan. 4. Major depression or bipolar disorder within past 1 year, past history of schizophrenia, defined by DSM-IV. 5. Addiction to alcohol or other drugs within past 2 years. 6. Past history of psychiatric symptoms, agitation or abnormal behaviors that affect protocol adherence within past 3 months. 7. Presence of fatal or unstable diseases. 8. Vitamin B12 or folate deficiency, syphilis, thyroid function abnormality. 9. Admission to care home or hospitals. 10. Administration of specific drugs (defined in J-ADNI2 procedure manual) including psychoactive drugs and warfarin. 11. Administration of any drugs in clinical trial within 1 month prior to screening. 12. Participation in clinical studies or clinical trials other than J-ADNI.
研究者
相似试验
已完成
不适用
Japanese Alzheimer's Disease Neuroimaging InitiativeAlzheimer's disease, mild cognitive impairment (MCI)JPRN-UMIN000001374J-ADNI study group600
尚未招募
不适用
Korean Alzheimer’s Disease Neuroimaging InitiativeMental and behavioral disordersKCT0001257Asan Medical Center500
已完成
不适用
Study on Diagnosis of early Alzheimer's disease-JapaMild Cognitive ImpairmentJPRN-C000000297Department of Brain Science and Molecular Imaging National Institute for Longevity Sciences National Center for Geriatrics and Gerontology150
进行中（未招募）
不适用
Amyloid Imaging in Alzheimer´s diseaseImaging amyloid plaques in patients with probable Alzheimer´s disease using [11C]PIB and [18F]FDDNP PETEUCTR2007-000148-28-ATDepartment of Neurology, Medical University of Vienna
已完成
不适用
Early diagnosis of Alzheimer's disease using resting-state fMRIAlzheimer'd diseaseJPRN-UMIN000022642Tokyo Metropolitan Institute of Gerontology40